The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications

Amir Hossein Miri,Mojtaba Kamankesh,Antoni Llopis-Lorente,Chenguang Liu,Matthias G. Wacker,Ismaeil Haririan,Hamid Asadzadeh Aghdaei,Michael R. Hamblin,Abbas Yadegar,Mazda Rad-Malekshahi,Mohammad Reza Zali
DOI: https://doi.org/10.3389/fphar.2022.917184
IF: 5.6
2022-01-01
Frontiers in Pharmacology
Abstract:Helicobacter pylori (H. pylori) is a notorious, recalcitrant and silent germ, which can cause a variety of debilitating stomach diseases, including gastric and duodenal ulcers and gastric cancer. This microbe predominantly colonizes the mucosal layer of the human stomach and survives in the inhospitable gastric microenvironment, by adapting to this hostile milieu. In this review, we first discuss H. pylori colonization and invasion. Thereafter, we provide a survey of current curative options based on polypharmacy, looking at pharmacokinetics, pharmacodynamics and pharmaceutical microbiology concepts, in the battle against H. pylori infection.
What problem does this paper attempt to address?